Company intelligence / Profile preview

OrganX

Oxford, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

OrganOx’s metra device is FDA and CE-mark approved for liver transplantation. Clinical and real-world studies show reduced organ discard, potential to expand donor criteria, and improved outcomes—over 4,000 transplants have used the system globally. A kidney device is in human trials.[1][2][5][6]

Therapeutic areas: NephrologyGastroenterology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on OrganX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrganX.

Explore the full profile